Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Vortioxetine hydrobromide tablets and preparation method thereof

A technology of vortioxetine hydrobromide and hydrobromic acid, which is applied in the field of medicine, can solve the problems of not being able to most effectively improve the efficiency of large-scale industrial production, the time-consuming granulation process, and the influence of drug stability, so as to save production costs , Solve light instability, good stability effect

Active Publication Date: 2015-12-30
KAMP PHARMA
View PDF4 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] Chinese Patent Publication No. CN104644594A discloses a vortioxetine hydrobromide stomach-dissolving tablet and a preparation method thereof, the raw materials of which include vortioxetine hydrobromide, a lubricant, a filler, a binder and a disintegrant; its preparation The method includes steps such as granulation, and the granulation process takes a long time. In this process, the drug is exposed to light, which easily degrades the raw materials, which has a certain impact on the stability of the drug, and the production cycle is long, so it cannot be most effectively improved. Efficiency of industrial mass production

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Vortioxetine hydrobromide tablets and preparation method thereof
  • Vortioxetine hydrobromide tablets and preparation method thereof
  • Vortioxetine hydrobromide tablets and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0036] A kind of vortioxetine hydrobromide tablet, its tablet core prescription is as follows:

[0037]

[0038]

Embodiment 2

[0040] A kind of vortioxetine hydrobromide tablet, its tablet core prescription is as follows:

[0041]

Embodiment 3

[0043] A kind of vortioxetine hydrobromide tablet, its tablet core prescription is as follows:

[0044]

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to vortioxetine hydrobromide tablets and a preparation method thereof, and belongs to the technical field of medicine. Tablet cores of the vortioxetine hydrobromide tablets are prepared from vortioxetine hydrobromide, mannitol, calcium phosphate dibasic, sodium carboxymethyl starch and magnesium stearate. A coating solution of the vortioxetine hydrobromide tablets is prepared from hydroxypropyl methylcellulose, polyethylene glycol 400, titanium dioxide, iron oxide yellow and purified water. The preparation method includes the steps that the raw materials of the tablet cores are screened, evenly mixed, directly subjected to tabletting and then subjected to coating. After the tablets are subjected to gastric-soluble film coating, the bitter taste of the tablets can be well avoided when the tablets are taken orally, and therefore compliance is improved. A film coating layer contains titanium dioxide, shading can be well achieved, it is avoided that the tablets are degraded under illumination, and therefore the stability of the tablets is improved.

Description

technical field [0001] The invention relates to a vortioxetine hydrobromide tablet and a preparation method thereof, belonging to the technical field of medicine. Background technique [0002] Vortioxetine was jointly developed by Lundbeck and Takeda Pharmaceuticals in the United States. It was approved by the U.S. Food and Drug Administration (FDA) on September 30, 2013 to be marketed in the United States. and 20mg for the treatment of major depressive disorder in adults. [0003] Chinese Patent Publication No. CN104644594A discloses a vortioxetine hydrobromide gastric dissolving tablet and a preparation method thereof, the raw materials of which include vortioxetine hydrobromide, lubricant, filler, binder and disintegrant; The method includes steps such as granulation, and the granulation process takes a long time. In the process, the drug is exposed to light to easily degrade the raw material, which has a certain impact on the stability of the drug, and the production cy...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/36A61K31/495A61K47/02A61K47/36A61K47/26A61P25/24
Inventor 吴健民郑和校张静贺莲
Owner KAMP PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products